Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, 827 Linden Avenue, Baltimore, MD, 21201, USA.
Division of Endocrinology, Baltimore Veterans Affairs Medical Center, 10 N. Greene Street, Baltimore, MD, 21201, USA.
Curr Diab Rep. 2018 Aug 29;18(10):87. doi: 10.1007/s11892-018-1067-4.
Hospitalized patients with diabetes are monitored with point-of-care glucose testing. Continuous glucose monitoring (CGM) devices represent an alternative way to monitor glucose values; however, the in-hospital CGM use is still considered experimental. Most inpatient studies used "blinded" CGM properties and only few used the real-time/unblinded CGM features. One major limitation of the CGM devices is that they need to be placed at the patients' bedside, limiting any therapeutic interventions. In this article, we review the real-time/unblinded CGM use and share our thoughts about the development of future inpatient CGM systems.
We recently reported that glucose values can be wirelessly transmitted to the nursing station, providing remote continuous glucose monitoring. Future inpatient CGM devices may be utilized for patients at risk for hypoglycemia similarly to the way that we use cardiac telemetry to monitor hospitalized patients who are at increased risk for cardiac arrhythmias.
住院糖尿病患者采用即时血糖检测进行监测。连续血糖监测(CGM)设备是监测血糖值的另一种方法;然而,住院期间 CGM 的使用仍被认为是实验性的。大多数住院患者研究使用了“盲法”CGM 特性,只有少数研究使用了实时/非盲法 CGM 特性。CGM 设备的一个主要限制是它们需要放置在患者床边,限制了任何治疗干预措施。本文综述了实时/非盲法 CGM 的应用,并分享了我们对未来住院 CGM 系统发展的看法。
我们最近报告称,血糖值可以通过无线传输到护士站,实现远程连续血糖监测。未来的住院 CGM 设备可用于有低血糖风险的患者,类似于我们使用心脏遥测来监测有更高心律失常风险的住院患者。